|
GB0603683D0
(en)
*
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
|
JP5059119B2
(ja)
|
2006-12-14 |
2012-10-24 |
シェーリング コーポレイション |
操作された抗ｔｓｌｐ抗体
|
|
WO2009094551A1
(en)
*
|
2008-01-25 |
2009-07-30 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
|
ES2784123T3
(es)
*
|
2009-11-04 |
2020-09-22 |
Merck Sharp & Dohme |
Anticuerpo anti TSLP genomodificado
|
|
MX360946B
(es)
*
|
2010-09-22 |
2018-10-29 |
Amgen Inc Star |
Inmunoglobulinas portadoras y usos de las mismas.
|
|
US9732151B2
(en)
*
|
2011-11-03 |
2017-08-15 |
Merck Sharp & Dohme Corp. |
Biomarkers for TSLP treatment
|
|
US9926373B2
(en)
*
|
2012-04-27 |
2018-03-27 |
Novo Nordisk A/S |
Human CD30 ligand antigen binding proteins
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
US9708375B2
(en)
|
2013-03-15 |
2017-07-18 |
Amgen Inc. |
Inhibitory polypeptides specific to WNT inhibitors
|
|
CN104371019B
(zh)
*
|
2013-08-13 |
2019-09-10 |
鸿运华宁（杭州）生物医药有限公司 |
一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质
|
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
|
EP3041863A4
(en)
|
2013-09-05 |
2017-08-16 |
Amgen Inc. |
Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
|
|
WO2015118124A1
(en)
*
|
2014-02-06 |
2015-08-13 |
Vib Vzw |
Thymic stromal lymphopoietin receptor antagonist
|
|
AU2015256082C1
(en)
|
2014-05-07 |
2020-09-10 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
|
US10156562B2
(en)
|
2014-05-16 |
2018-12-18 |
Amgen Inc. |
Assay for detecting Th1 and Th2 cell populations
|
|
CN111840696B
(zh)
|
2014-06-03 |
2022-12-20 |
安姆根有限公司 |
可控制药物递送系统和使用方法
|
|
EP3206739B1
(en)
|
2014-10-14 |
2021-12-01 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
WO2016065181A1
(en)
|
2014-10-23 |
2016-04-28 |
Amgen Inc. |
Reducing viscosity of pharmaceutical formulations
|
|
US11357916B2
(en)
|
2014-12-19 |
2022-06-14 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
JP6484345B2
(ja)
|
2015-02-17 |
2019-03-20 |
アムジエン・インコーポレーテツド |
固定及び／または戻りが真空によって支援された薬物送達装置
|
|
WO2016138434A1
(en)
|
2015-02-27 |
2016-09-01 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
KR20170123315A
(ko)
*
|
2015-03-11 |
2017-11-07 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Tslp 결합 단백질
|
|
US9708412B2
(en)
|
2015-05-21 |
2017-07-18 |
Harpoon Therapeutics, Inc. |
Trispecific binding proteins and methods of use
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
HRP20210650T1
(hr)
|
2015-09-09 |
2021-05-28 |
Novartis Ag |
Protutijela koja vežu timusni stromalni limfopoetin (tslp) i postupci uporabe protutijela
|
|
EA038332B1
(ru)
*
|
2015-09-09 |
2021-08-10 |
Новартис Аг |
Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул
|
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
RU2757314C2
(ru)
|
2016-01-22 |
2021-10-13 |
Мерк Шарп И Доум Корп. |
Антитела против фактора свертывания xi
|
|
GB201615588D0
(en)
*
|
2016-09-14 |
2016-10-26 |
Glaxosmithkline Ip Dev Ltd |
TSLP Binding Proteins
|
|
DK3429663T3
(da)
|
2016-03-15 |
2020-09-28 |
Amgen Inc |
Reduktion af sandsynligheden for glasbrud i anordninger til indgivelse af lægemidler
|
|
US11001624B2
(en)
*
|
2016-04-05 |
2021-05-11 |
Vib Vzw |
TSLP inhibitors
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
AU2017263558B2
(en)
|
2016-05-13 |
2022-12-22 |
Amgen Inc. |
Vial sleeve assembly
|
|
WO2017200989A1
(en)
|
2016-05-16 |
2017-11-23 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
EP3493844A4
(en)
|
2016-05-20 |
2021-03-24 |
Harpoon Therapeutics Inc. |
SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN
|
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
IL315266A
(en)
|
2016-06-14 |
2024-10-01 |
Merck Sharp ַ& Dohme Llc |
Anti-coagulation factor xi antibodies
|
|
EP3478342B1
(en)
|
2016-07-01 |
2025-03-12 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
RU2721582C1
(ru)
*
|
2016-08-05 |
2020-05-20 |
И-Байолоджикс Инк. |
Антитела против лиганда-1 запрограммированной смерти (PD-L1) и их применение
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
|
TWI784988B
(zh)
|
2016-12-01 |
2022-12-01 |
美商再生元醫藥公司 |
治療發炎症狀的方法
|
|
AU2018210301A1
(en)
|
2017-01-17 |
2019-08-01 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
CA3045376C
(en)
*
|
2017-01-24 |
2022-08-30 |
I-Mab |
Anti-cd73 antibodies and uses thereof
|
|
CA3052204A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
WO2018151890A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
JP7377596B2
(ja)
|
2017-02-22 |
2023-11-10 |
アムジエン・インコーポレーテツド |
低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
|
|
EP3592403B1
(en)
|
2017-03-06 |
2025-08-20 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
|
US11571511B2
(en)
|
2017-03-07 |
2023-02-07 |
Amgen Inc. |
Insertion mechanism and method of inserting a needle of a drug delivery device
|
|
AU2018230486B2
(en)
|
2017-03-09 |
2023-05-11 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
CA3056011A1
(en)
|
2017-03-14 |
2018-09-20 |
Amgen Inc. |
Control of total afucosylated glycoforms of antibodies produced in cell culture
|
|
ES3023742T3
(en)
|
2017-03-28 |
2025-06-03 |
Amgen Inc |
Plunger rod and syringe assembly system
|
|
KR102666879B1
(ko)
*
|
2017-04-12 |
2024-05-23 |
암젠 인크 |
항-tslp 항체를 이용한 천식의 치료
|
|
WO2018201064A1
(en)
|
2017-04-28 |
2018-11-01 |
Amgen Inc. |
N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
|
|
JP7200134B2
(ja)
|
2017-06-08 |
2023-01-06 |
アムジエン・インコーポレーテツド |
トルク駆動式薬物送達デバイス
|
|
US11590294B2
(en)
|
2017-06-08 |
2023-02-28 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
JP7195276B2
(ja)
|
2017-06-22 |
2022-12-23 |
アムジエン・インコーポレーテツド |
デバイス起動による衝突／衝撃の低減
|
|
WO2018237225A1
(en)
|
2017-06-23 |
2018-12-27 |
Amgen Inc. |
Electronic drug delivery device comprising a cap activated by a switch assembly
|
|
CN109206514B
(zh)
*
|
2017-07-03 |
2019-10-08 |
拜西欧斯（北京）生物技术有限公司 |
Tslp单克隆抗体及其制备方法和应用
|
|
IL270784B2
(en)
|
2017-07-14 |
2023-11-01 |
Amgen Inc |
Needle insertion-extraction system with a double torsion spring system
|
|
JP7649105B2
(ja)
|
2017-07-21 |
2025-03-19 |
アムジエン・インコーポレーテツド |
薬物容器のためのガス透過性シーリング部材及び組立方法
|
|
US11617837B2
(en)
|
2017-07-25 |
2023-04-04 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
|
MA49676A
(fr)
|
2017-07-25 |
2020-06-03 |
Amgen Inc |
Dispositif d'administration de médicament doté d'un système d'accès à un récipient et procédé d'assemblage associé
|
|
ES2978396T3
(es)
|
2017-08-01 |
2024-09-11 |
Amgen Inc |
Sistemas y métodos para la preparación en tiempo real de una muestra de polipéptidos para el análisis por espectrometría de masas
|
|
MX2020001171A
(es)
|
2017-08-01 |
2020-03-12 |
Amgen Inc |
Sistemas y metodos para realizar un ensayo de glicanos en tiempo real de una muestra.
|
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
|
EP3669004A1
(en)
|
2017-08-16 |
2020-06-24 |
Medimmune, LLC |
Compositions and methods for treatment of atopic dermatitis and treatment selection
|
|
EP3668567B1
(en)
|
2017-08-18 |
2026-02-18 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
WO2019070472A1
(en)
|
2017-10-04 |
2019-04-11 |
Amgen Inc. |
FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE
|
|
ES2971450T3
(es)
|
2017-10-06 |
2024-06-05 |
Amgen Inc |
Dispositivo de administración de fármacos con conjunto de enclavamiento y procedimiento de montaje correspondiente
|
|
US11464903B2
(en)
|
2017-10-09 |
2022-10-11 |
Amgen Inc. |
Drug delivery device with drive assembly and related method of assembly
|
|
MX2020003915A
(es)
|
2017-10-13 |
2020-10-08 |
Harpoon Therapeutics Inc |
Proteinas trispecificas y metodos de uso.
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
IL273582B2
(en)
|
2017-11-03 |
2024-12-01 |
Amgen Inc |
Systems and approaches for sterilizing a drug delivery device
|
|
EP3706830B1
(en)
|
2017-11-06 |
2024-08-07 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
|
EP3707075A1
(en)
|
2017-11-06 |
2020-09-16 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
|
MA50557A
(fr)
|
2017-11-10 |
2020-09-16 |
Amgen Inc |
Pistons pour dispositifs d'administration de médicament
|
|
JP7370969B2
(ja)
|
2017-11-16 |
2023-10-30 |
アムジエン・インコーポレーテツド |
薬物送達デバイスの扉ラッチ機構
|
|
EP4321870B1
(en)
|
2018-03-13 |
2025-07-30 |
Amgen Inc. |
Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
|
|
KR102775717B1
(ko)
|
2018-03-13 |
2025-03-06 |
암젠 인크 |
질량 분광 분석을 위한 폴리펩티드의 순차적 소화
|
|
US12325737B2
(en)
|
2018-03-26 |
2025-06-10 |
Amgen Inc. |
Total afucosylated glycoforms of antibodies produced in cell culture
|
|
BR112020023330A2
(pt)
|
2018-05-14 |
2021-04-20 |
Harpoon Therapeutics, Inc. |
porção de ligação para ativação condicional de moléculas de imunoglobulina
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
CA3103681A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
MA53375A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
|
CA3103105A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
US12195544B2
(en)
|
2018-09-21 |
2025-01-14 |
Harpoon Therapeutics, Inc. |
EGFR binding proteins and methods of use
|
|
US20210346601A1
(en)
|
2018-09-24 |
2021-11-11 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
US10815311B2
(en)
|
2018-09-25 |
2020-10-27 |
Harpoon Therapeutics, Inc. |
DLL3 binding proteins and methods of use
|
|
CA3110371A1
(en)
|
2018-09-28 |
2020-04-02 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
|
EP3860685A1
(en)
|
2018-10-02 |
2021-08-11 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
US12151089B2
(en)
|
2018-10-05 |
2024-11-26 |
Amgen Inc. |
Drug delivery device having dose indicator
|
|
TW202541859A
(zh)
|
2018-10-15 |
2025-11-01 |
美商安進公司 |
具有阻尼機構之藥物遞送裝置及自動注射器
|
|
WO2020081480A1
(en)
|
2018-10-15 |
2020-04-23 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
|
EP3873563A1
(en)
|
2018-11-01 |
2021-09-08 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
MA54048A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament avec rétraction partielle de l'organe d'administration de médicament
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
AU2019396614B2
(en)
|
2018-12-14 |
2025-07-10 |
Amgen Inc. |
System suitability method for use with protein concentration determination by slope
|
|
US11452738B2
(en)
|
2019-01-04 |
2022-09-27 |
Empirico Inc. |
Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts
|
|
JP7483731B2
(ja)
|
2019-02-14 |
2024-05-15 |
アムジエン・インコーポレーテツド |
試料の調製及びその試料のリアルタイムアッセイの実施のためのシステム及び方法
|
|
WO2020172293A1
(en)
|
2019-02-20 |
2020-08-27 |
Amgen Inc. |
Methods of determining protein stability
|
|
US20230035363A1
(en)
|
2019-03-04 |
2023-02-02 |
Amgen Inc. |
In vivo reversibility of high molecular weight species
|
|
US12078701B2
(en)
|
2019-03-27 |
2024-09-03 |
Amgen Inc. |
Methods of fingerprinting therapeutic proteins via a two-dimensional (2D) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
|
|
AU2020263289B2
(en)
|
2019-04-24 |
2025-05-22 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
JP7628966B2
(ja)
|
2019-06-04 |
2025-02-12 |
ジエンス ヘンルイ メデイシンカンパニー リミテッド |
胸線間質性リンパ球増殖因子に結合可能な抗体およびその使用
|
|
AU2020288652A1
(en)
|
2019-06-05 |
2021-11-18 |
Amgen Inc. |
Methods of identifying attributes of therapeutic proteins
|
|
CA3147044A1
(en)
|
2019-07-11 |
2021-01-14 |
Tavotek Biotherapeutics (Hong Kong) Limited |
Agents that interfere with thymic stromal lymphopoietin (tslp)-receptor signaling
|
|
WO2021041067A2
(en)
|
2019-08-23 |
2021-03-04 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
|
BR112022005583A2
(pt)
|
2019-09-26 |
2022-09-20 |
Amgen Inc |
Métodos para a produção de composições de anticorpos
|
|
PH12022551022A1
(en)
*
|
2019-10-28 |
2023-03-06 |
Medimmune Ltd |
Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof
|
|
CN114887053B
(zh)
*
|
2019-11-29 |
2026-04-24 |
康诺亚生物医药科技（成都）有限公司 |
一种tslp相关病症治疗剂的开发和应用
|
|
AU2020400221A1
(en)
*
|
2019-12-13 |
2022-05-19 |
Harbour Biomed (Shanghai) Co., Ltd. |
Anti-TSLP antibody and uses thereof
|
|
TW202140550A
(zh)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
|
|
CN111171150B
(zh)
*
|
2020-02-05 |
2020-12-08 |
北京智仁美博生物科技有限公司 |
抗人tslp抗体及其用途
|
|
EP4103605A1
(en)
|
2020-02-13 |
2022-12-21 |
Amgen Inc. |
Treatment of atopic dermatitis with anti-tslp antibody
|
|
MX2022010012A
(es)
|
2020-02-13 |
2022-09-07 |
Amgen Inc |
Formulaciones de anticuerpos anti-tslp humanos y métodos de tratamiento de una enfermedad inflamatoria.
|
|
IL295511A
(en)
|
2020-02-18 |
2022-10-01 |
Amgen Inc |
Formulations of human anti-tslp antibodies and methods of using them
|
|
CN111662379B
(zh)
*
|
2020-05-09 |
2021-03-02 |
江苏省疾病预防控制中心(江苏省公共卫生研究院) |
抗新型冠状病毒的抗体、制备方法和应用
|
|
EP4153625A4
(en)
*
|
2020-05-20 |
2024-09-25 |
The Trustees Of Columbia University In The City Of New York |
STRONG NEUTRALISING ANTIBODIES AGAINST SARS-COV-2, THEIR PRODUCTION AND USE
|
|
US20230273126A1
(en)
|
2020-06-04 |
2023-08-31 |
Amgen Inc. |
Assessment of cleaning procedures of a biotherapeutic manufacturing process
|
|
MX2023003164A
(es)
|
2020-09-18 |
2023-05-04 |
Amgen Inc |
Metodos de procesamiento de una muestra para analisis de mapeo de peptidos.
|
|
KR20230087539A
(ko)
|
2020-10-15 |
2023-06-16 |
암젠 인크 |
항체 생산 방법에서의 상대적인 비결합 글리칸
|
|
EP4240747A1
(en)
|
2020-11-05 |
2023-09-13 |
Amgen Inc. |
Materials and methods for protein processing
|
|
CN114437212B
(zh)
*
|
2020-11-06 |
2023-03-14 |
上海麦济生物技术有限公司 |
抗人胸腺基质淋巴细胞生成素抗体及其制备方法和应用
|
|
WO2022117079A1
(zh)
*
|
2020-12-03 |
2022-06-09 |
江苏恒瑞医药股份有限公司 |
结合胸腺基质淋巴细胞生成素的抗体及其应用
|
|
CN113501878B
(zh)
|
2021-02-03 |
2022-12-02 |
北京智仁美博生物科技有限公司 |
针对人tslp的多种抗体及其用途
|
|
US20250277022A1
(en)
*
|
2021-02-04 |
2025-09-04 |
Staidson (Beijing) Biopharmaceuticals Co., Ltd. |
Antibodies specifically recognizing thymic stromal lymphopoietin and uses thereof
|
|
KR20230175245A
(ko)
*
|
2021-04-23 |
2023-12-29 |
암젠 인크 |
변형된 항-tslp 항체
|
|
EP4326766A1
(en)
|
2021-04-23 |
2024-02-28 |
Amgen Inc. |
Anti-tslp antibody compositions and uses thereof
|
|
JP2024523779A
(ja)
|
2021-05-21 |
2024-07-02 |
アムジェン インコーポレイテッド |
薬物容器用の充填レシピを最適化する方法
|
|
IL308360A
(en)
*
|
2021-05-30 |
2024-01-01 |
Biolojic Design Ltd |
Engineered dual binding antibodies and uses thereof
|
|
EP4352094A1
(en)
|
2021-06-07 |
2024-04-17 |
Amgen Inc. |
Using fucosidase to control afucosylation level of glycosylated proteins
|
|
CN113069543B
(zh)
*
|
2021-06-07 |
2021-08-06 |
迈威(上海)生物科技股份有限公司 |
包含抗胸腺基质淋巴细胞生成素的单克隆抗体的液体组合物
|
|
CN113683694B
(zh)
|
2021-09-03 |
2022-05-13 |
江苏荃信生物医药股份有限公司 |
一种抗人tslp单克隆抗体及其应用
|
|
US20250076309A1
(en)
|
2021-10-05 |
2025-03-06 |
Amgen Inc. |
Fc-gamma receptor ii binding and glycan content
|
|
WO2023070948A1
(zh)
*
|
2021-11-01 |
2023-05-04 |
江苏荃信生物医药股份有限公司 |
包含抗人胸腺基质淋巴细胞生成素(tslp)单克隆抗体的浓缩溶液的制备方法及液体制剂
|
|
EP4430174A1
(en)
|
2021-11-09 |
2024-09-18 |
Amgen Inc. |
Production of therapeutic proteins
|
|
CN117209603B
(zh)
*
|
2021-12-02 |
2024-02-27 |
北京东方百泰生物科技股份有限公司 |
一种抗tslp的单克隆抗体、其抗原结合片段及其应用
|
|
CN114369654B
(zh)
*
|
2021-12-21 |
2023-11-07 |
广州市妇女儿童医疗中心 |
川崎病的生物标志物及其应用
|
|
JP2025500971A
(ja)
*
|
2021-12-24 |
2025-01-15 |
インマージーン プライベート リミテッド |
新規の抗ｔｓｌｐ抗体
|
|
US20240117030A1
(en)
*
|
2022-03-03 |
2024-04-11 |
Pfizer Inc. |
Multispecific antibodies and uses thereof
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
US12110324B2
(en)
|
2022-07-22 |
2024-10-08 |
Flagship Pioneering Innovations Vi, Llc |
Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)
|
|
CN116162154B
(zh)
*
|
2022-10-21 |
2024-06-11 |
珠海泰诺麦博制药股份有限公司 |
抗人巨细胞病毒抗体及其用途
|
|
TW202426485A
(zh)
|
2022-10-26 |
2024-07-01 |
美商安進公司 |
抗ｔｓｌｐ抗體組成物及其用途
|
|
TW202448501A
(zh)
|
2023-02-02 |
2024-12-16 |
美商麥迪紐有限責任公司 |
用抗ｔｓｌｐ抗體治療慢性鼻竇炎
|
|
EP4678659A1
(en)
*
|
2023-02-23 |
2026-01-14 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Monoclonal antibody preparation targeting tslp
|
|
AU2024256160A1
(en)
|
2023-04-20 |
2025-10-02 |
Amgen Inc. |
Methods of determining relative unpaired glycan content
|
|
IL324470A
(en)
|
2023-05-18 |
2026-01-01 |
Medimmune Llc |
Treatment of corticosteroid-dependent asthma using anti-TSLP antibody
|
|
KR20260020485A
(ko)
|
2023-06-14 |
2026-02-11 |
브리스톨-마이어스 스큅 컴퍼니 |
당단백질의 준실시간 시알산 정량화
|
|
WO2024264002A2
(en)
*
|
2023-06-22 |
2024-12-26 |
Paragon Therapeutics, Inc. |
Antibodies that bind tslp and tslpr and methods of use
|
|
CN121816362A
(zh)
*
|
2023-06-22 |
2026-04-07 |
派拉冈医疗公司 |
结合白细胞介素13和tslp或tslpr的抗体及其使用方法
|
|
WO2025038600A1
(en)
|
2023-08-14 |
2025-02-20 |
Amgen Inc. |
Methods for reducing yellow color
|
|
AU2024334289A1
(en)
|
2023-08-25 |
2026-04-09 |
Proteologix Us Inc. |
Anti-il-13 multispecific antibody constructs and uses thereof
|
|
AR134102A1
(es)
*
|
2023-10-12 |
2025-12-03 |
Innovent Biologics Suzhou Co Ltd |
ANTICUERPOS ANTI-IL-4Ra Y USOS DE LOS MISMOS
|
|
WO2025101602A1
(en)
|
2023-11-07 |
2025-05-15 |
Amgen Inc. |
Methods of analyzing amino acid content of a therapeutic protein
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2025147632A1
(en)
|
2024-01-05 |
2025-07-10 |
Medimmune, Llc |
Treatment of chronic obstructive pulmonary disease with anti-tslp antibody
|
|
WO2025221247A1
(en)
|
2024-04-17 |
2025-10-23 |
Amgen Inc. |
Treatment of eosinophilic esophagitis with anti-tslp antibody
|
|
WO2025255028A1
(en)
|
2024-06-03 |
2025-12-11 |
Amgen Inc. |
High-throughput liquid chromatography-mass spectrometry-based peptide mapping
|
|
WO2025264860A2
(en)
|
2024-06-18 |
2025-12-26 |
Yale University |
Methods of treating post-covid airway disease
|
|
WO2025265071A1
(en)
*
|
2024-06-21 |
2025-12-26 |
Paragon Therapeutics, Inc. |
Antibodies that bind tslp and methods of use
|
|
WO2026030152A1
(en)
|
2024-07-29 |
2026-02-05 |
Amgen Inc. |
System and method for assessing transferability of a fill recipe
|
|
WO2026067826A1
(zh)
*
|
2024-09-30 |
2026-04-02 |
深圳市小分子新药创新中心有限公司 |
抗tslp单域抗体及其衍生物
|